SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rita who wrote (158)8/21/1999 1:44:00 PM
From: John McCarthy  Read Replies (3) of 315
 
CLZR:First Quarter - Fiscal 2000 ...........

Candela will release their 4th Quarter and Full Year Results on
August 24th at 10:30 A.M. At that time they also plan to hold
a Conference Call.

Just guessing, but no doubt, see E.G.Harmons (and others) UPCOMING post(s) to Yahoo after the Conference Call which will fill everyone in on what was communicated at the CC. I am hoping R. Davis will also MAKE AN APPEARANCE on this thread and comment on the Conference call.

The PURPOSE OF THIS POST is to look FORWARD and SPECULATE about Candela's upcoming Q1- Fiscal Year 2000 RESULTS which will probably be announced on or around OCTOBER 19TH, 1999 i.e. ABOUT 8 WEEKS FROM today.

These are the numbers we have to BEAT in Q1 - Fiscal Year 2000.

------------------------------
First Quarter - Last Year (1999)
------------------------------
Revenues:$10,738
------------------------------
Memo:Product:$8,022
Memo:Service:$2,716
Memo:Total:$10,738
------------------------------
EAT:$910
------------------------------
Diluted E.P.S:$0.16
------------------------------
Shares:5,566
------------------------------
Gross Margin %:47.2
------------------------------
Operating Expenses %:37.4
------------------------------
Cash:$2,463
------------------------------
Short Term Debt:$2,945
------------------------------
Long Term Debt:$495

Source:
sec.gov

-------------------------------------------------------
Revenue Sources not available in Q1 - 1999
------------------------------------------------------
(1) GentleLase contract with PSSI - 100,000 new targets

(2) GentleLase approval in BRAZIL - 16,000 new targets

(3) Lease GentleLases' to Electrologists - 6000 new targets

"we have recently begun an innovative leasing program to target the
estimated 6,000 electrologists in the U.S. as potential customers of the
GentleLASE for hair removal"

sec.gov

(4) Re-Opened Sales Office in Germany - Central European Market

(5) New Sales Office in Osaka, Japan - "Branch to Boost Sales"

businesswire.com

(6) French-developed Skintonic(TM) massage system.

"fast-growing body and face massage market "

businesswire.com

(7) Skin Exfoliation System

"aesthetic skin care. "

businesswire.com

------------------------------------------------------
Speculation:
------------------------------------------------------
The question I want to post to this board is can the
new Revenue sources provide an ADDITIONAL
$8.0 million in revenue.

Stated another way - can CLZR *double* year over year
revenues based on the new revenue sources above.

Here is an off the cuff speculation on my part:

(1) PSSI - $2.0 million
(2) Brazil - $0.5 million
(3) Electrologists - $0.5 million
(4) Germany Offic - $0.5 million
(5) Osaka Office - $1.0 million
(6) Skintonic(TM) - $0.5 million
(7) Skin Exfoliation System - $0.5 million

Total Revenue from NEW SOURCES or NEW PRODUCTS:$5.5 million

Comments, ideas, critisims , etc. welcome.

Note:I posted the above to Yahoo and put it here as
an FYI.

regards,
John McCarthy (DECAID on Yahoo)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext